[Heterogeneity of childhood diabetes and its therapeutic implications]

Vnitrni Lekarstvi
|December 7, 2016
PubMed

Insights

The incidence of childhood diabetes in the Czech Republic has tripled in 25 years, with Type 1 and monogenic forms being most common. Accurate etiological diagnosis is crucial for effective treatment of pediatric diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Genetics of Diabetes

Background:

  • Diabetes prevalence in Czech children is 1:500-1:1000, with incidence tripling over 25 years.
  • Type 1 diabetes is the predominant form in childhood, alongside frequent diagnoses of monogenic diabetes.
  • Type 2 diabetes remains rare, accounting for less than 1% of pediatric diabetes cases in the Czech Republic.

Purpose of the Study:

  • To review novel aspects of etiology and therapy for diabetes diagnosed in childhood and adolescence.
  • To highlight the importance of etiological diagnosis for effective diabetes management in pediatric populations.
  • To provide an updated overview of the current landscape of pediatric diabetes in the Czech Republic.

Main Methods:

  • Literature review focusing on recent advancements in pediatric diabetes etiology.
  • Analysis of epidemiological data on diabetes incidence and prevalence in Czech children.
  • Synthesis of current therapeutic approaches for various forms of childhood diabetes.

Main Results:

  • Significant increase in diabetes incidence over the past 25 years.
  • Type 1 and monogenic diabetes are the most frequently diagnosed forms in Czech children.
  • Type 2 diabetes represents a minimal proportion of pediatric diabetes cases.

Conclusions:

  • Accurate etiological diagnosis is fundamental for tailoring effective diabetes treatment in children and adolescents.
  • Understanding the evolving landscape of pediatric diabetes, including monogenic forms, is critical.
  • Further research into novel therapeutic strategies for pediatric diabetes is warranted.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K